Results 41 to 50 of about 21,513 (220)

Estudio de las manifestaciones extraarticulares en pacientes con espondiloartritis en el área de salud de La Plana [PDF]

open access: yes, 2017
Treball Final de Grau en Grau en Medicina. Codi: MD1158. Curs: 2016/2017Objetivos: La uveítis, psoriasis y enfermedad inflamatoria intestinal son las manifestaciones extraarticulares que más frecuentemente se asocian a las Espondiloartropatías (EsA ...
Lis Sancerni, María Dolores
core  

Updated insights into the molecular pathogenesis of canine atopic dermatitis

open access: yesVeterinary Dermatology, Volume 36, Issue 4, Page 375-384, August 2025.
Abstract Atopic dermatitis (AD) is a common and chronic inflammatory skin disease with frequent relapses. The genomics revolution has greatly contributed and revolutionised our knowledge of human AD; understanding the molecular skin fingerprint of AD and associated pathogenic immune pathways has led to preclinical assessments of several novel ...
Frane Banovic
wiley   +1 more source

Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU

open access: yesRevista de Gastroenterología de México (English Edition), 2022
Introduction: Inflammatory bowel disease (IBD) is a chronic and incurable entity. The aim of the Pan American Crohn's and Colitis Organisation (PANCCO) is to create awareness of IBD, with special emphasis on Latin America, and the primary objective of ...
J.K. Yamamoto-Furusho   +13 more
doaj   +1 more source

Frecuencia de autoanticuerpos y niveles de calprotectina fecal en un grupo de pacientes con enfermedad inflamatoria intestinal [PDF]

open access: yes, 2014
La enfermedad inflamatoria intestinal (EII) comprende dos entidades, la colitis ulcerativa (CU) y la enfermedad de Crohn (ECr). La evidencia sugiere que la EII es el resultado de una inapropiada respuesta inflamatoria a la flora intestinal en el contexto
Garcia Leyton, Ferney   +3 more
core  

Macronutrients as Regulators of Intestinal Epithelial Permeability: Where Do We Stand?

open access: yesComprehensive Reviews in Food Science and Food Safety, Volume 24, Issue 3, May 2025.
ABSTRACT The intestinal barrier function (IBF) is essential for intestinal homeostasis. Its alterations have been linked to intestinal and systemic disease. Regulation of intestinal permeability is key in the maintenance of the IBF, in which the intestinal epithelium and tight junctions, the mucus layer, sIgA, and antimicrobial peptides are important ...
Olga Martínez‐Augustin   +9 more
wiley   +1 more source

A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease

open access: yesAnales de Pediatría (English Edition), 2018
Background and objectives: Adalimumab (ADA), a monoclonal humanised anti-TNF antibody, is usually prescribed as a second-line treatment in paediatric Crohn's disease (CD) patients who have become unresponsive or developed intolerance to infliximab (IFX).
Víctor Manuel Navas-López   +7 more
doaj   +1 more source

Papel de los polifenoles en la EII: nuevas propuestas relacionadas con el microbioma y con el succinato [PDF]

open access: yes, 2019
La Enfermedad Inflamatoria Intestinal (EII) se caracteriza por ser un trastorno crónico inflamatorio que afecta al tracto gastrointestinal.
Chaves Blanco, Lucía
core  

Hypoxia inducible factor 3‐alpha promotes a malignant phenotype in colorectal cancer cells

open access: yesIUBMB Life, Volume 77, Issue 2, February 2025.
Abstract Colorectal cancer (CRC) is the third most common cancer worldwide. Hypoxia is a hallmark of the tumor microenvironment, and cellular adaptation to it is primarily mediated by the family of Hypoxia‐inducible factors (HIFs) HIF‐1α, HIF‐2α, and HIF‐3α. However, in contrast to HIF‐1α and HIF‐2α, a specific role for HIF‐3α in cancer biology has not
Alejandro Lopez‐Mejia   +7 more
wiley   +1 more source

Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn

open access: yesAnales de Pediatría, 2018
Resumen: Introducción y objetivos: Adalimumab (ADA), anticuerpo anti-TNF-α monoclonal recombinante de origen humano, generalmente se emplea como tratamiento de segunda línea en niños con enfermedad de Crohn (EC) que no han respondido o han perdido ...
Víctor Manuel Navas-López   +7 more
doaj   +1 more source

Tiempo hasta el diagnóstico en la enfermedad inflamatoria intestinal pediátrica: claves para un diagnóstico precoz

open access: yesAnales de Pediatría, 2020
Resumen: La enfermedad inflamatoria intestinal pediátrica continúa siendo poco prevalente en nuestro medio. El comienzo de los síntomas puede ser insidioso y el diagnóstico precoz permite disminuir las complicaciones y las secuelas de la enfermedad, así ...
Javier Martín-de-Carpi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy